MedCon 2024, co-sponsored by the FDA

2024 MedCon Workshop

this year’s theme

AI/ML Enabled Medical Devices from a Quality & Regulatory Perspective: an Interactive Workshop

As the number of Artificial Intelligence and Machine Learning (AI/ML)-enabled medical devices cleared by FDA approaches 1,000, the challenges associated with incorporating this technology are still significant. The level of understanding around AI/ML fundamental concepts in the industry is still very low; regulatory frameworks are not yet designed to take advantage of the greatest benefits of AI/ML, and there are many barriers to trust in these technologies to safely and effectively diagnose and treat patients (e.g., bias, transparency, explainability).

This daylong workshop aligns attendees on vocabulary and concepts and includes a hands-on session that takes a simple AI algorithm and moves it through the training, testing, and tuning process. The workshop will also include:

An overview of current and future regulatory trends in AI/ML-enabled medical devices

The impact of AI/ML on Quality and Regulatory functions

Technology, intended use, and trustworthiness challenges that the medical device industry and regulators must address

A case study walking attendees through development, submission, clearance, and deployment of an AI/ML-enabled medical device

Don’t miss this opportunity to engage with thought leaders who have had significant impact on the global discussion around these topics.

workshop Facilitators

Cassie Scherer

Medtronic

Erez Kaminski

Ketryx

Eric Henry

King & Spalding

Jason Brooke

Brooke & Associates

Mandar karhade

Citingale

Yarmela Pavlovic

Medtronic

APRIL 23, 2024 — MedCon Workshop Agenda

9:00 a.m. – 10:00 a.m.

Intro

  • Welcome and Introduction to the Workshop
  • Brief Overview of AI in the Medical Devices Industry (technologies and use cases)
  • Key AI Concepts (machine learning, natural language processing, computer vision)
Speakers

Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding

Erez Kaminski, CEO & Founder, Ketryx

10:00 a.m. – 10:45 a.m.

Regulatory Landscape for AI in Medical Devices

  • Overview of current and future regulatory frameworks (U.S. and global) for medical devices
Speaker

Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding

10:45 a.m. – 11:00 a.m.

Break

11:00 a.m. – 12:00 noon

Quality Assurance with AI in Medical Devices

  • Medical device AI/ML use cases 
  • Role of AI supporting the QMS 
  • Role of AI in enhancing quality control processes (manufacturing) 
  • Addressing challenges and opportunities in compliance 
  • AI and safety risk management 
Speaker 

Jason Brooke, Attorney & Managing Member, Brooke & Associates 

12:00 noon – 1:00 p.m.

Lunch

1:00 p.m. – 2:00 p.m.

Future Trends and Challenges

  • Emerging trends in AI for medical devices and their regulatory impact 
  • Bias 
  • Transparency/explainability 
  • Nutrition labels 
  • Assurance labs 
  • Other anticipated regulatory challenges and potential solutions for AI/ML 
Speakers

Yarmela Pavlovic, VP Global Regulatory Affairs, Strategy & Policy, Medtronic 

Cassie Scherer, Senior Director U.S. Regulatory and Global Digital Health Policy, Medtronic

2:00 p.m. – 3:00 p.m.

Interactive Session: Building an AI-Enabled Medical Device Overview

  • Overview of a sample medical device project 
  • Hands-on demo using AI tools 
Speaker

Mandar Karhade, Founder, Citingale

3:00 p.m. – 3:15 p.m.

Break

3:15 p.m. – 4:00 p.m.

Case Studies: Successful Implementation of AI in Medical Devices

  • Real-world examples of AI integration in medical devices 
  • Highlighting positive outcomes in terms of efficiency and compliance 
  • Lessons learned and best practices from these cases 
Speaker

Erez Kaminski, CEO & Founder, Ketryx 

4:00 p.m. – 4:30 p.m.

Conclusion and Networking

  • Recap of key takeaways 
  • Opportunities for further learning and collaboration 
Speaker

Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding 

Because of the generosity of our supporters, we can continue our work to improve the healthcare products industry.

Abbott, sponsor

Diamond Sponsor

Zimmer Biomet, sponsor

Platinum Sponsor

Steris, Sponsor

Platinum Sponsor

Eli Lilly, sponsor

Gold Sponsor

Johnson Johnson, sponsor

Gold Sponsor

Learn more about supporting MedCon 2024 through sponsorship by contacting Patrick Flynn at +1-301-770-2920, ext. 246, or pflynn@raps.org.

This conference is co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.